Indirubin-3′-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration-Reference-Cited by-同舟云学术

Indirubin-3′-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration

Published:2013-12-23 Issue:3 Volume:101 Page:522-532
ISSN:1755-3245
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Blažević Tina,Schaible Anja M.,Weinhäupl Katharina,Schachner Daniel,Nikels Felix,Weinigel Christina,Barz Dagmar,Atanasov Atanas G.,Pergola Carlo,Werz Oliver,Dirsch Verena M.,Heiss Elke H.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/101/3/522/17395293/cvt339.pdf

Reference40 articles.

1. Indirubin-3′-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo;Schwaiberger;Arterioscler Thromb Vasc Biol,2010

2. Inflammation, atherosclerosis, and coronary artery disease;Hansson;N Engl J Med,2005

3. Inflammatory signaling through leukotriene receptors in atherosclerosis;Back;Curr Atheroscler Rep,2008

4. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis;Hlawaty;Arterioscler Thromb Vasc Biol,2009

5. Leukotrienes;Peters-Golden;N Engl J Med,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of PANoptosis-related genes and the immune landscape in moyamoya disease;Scientific Reports;2024-05-04

2. Aryl hydrocarbon receptor: A bridge linking immuno-inflammation and metabolism in atherosclerosis;Biochemical Pharmacology;2023-10

3. Pharmacological properties of indirubin and its derivatives;Biomedicine & Pharmacotherapy;2022-07

4. Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma;eBioMedicine;2022-04

5. Drug delivery of 6-bromoindirubin-3’-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents;Journal of Nanobiotechnology;2022-01-04